About Careers MedBlog Contact us

Nano-Sensor Detects Cancer Even Before Initial Symptoms Appear, Prevents Need for Biopsy

by Bidita Debnath on April 9, 2015 at 2:02 AM
Font : A-A+

Nano-Sensor Detects Cancer Even Before Initial Symptoms Appear, Prevents Need for Biopsy

A 35-year-old Brazilian scientist, Priscila Kosaka, has developed a new method to detect cancer before initial symptoms appear and without the need for a biopsy.

Kosaka has been working at the Microelectronic Institute of Madrid (Spain) for the past six years, and has developed a less invasive method that uses a nano-sensor that is "10 million times more effective" than traditional tests on patient blood samples.


The sensor has antibodies that can capture cancerous cells when they come into contact with an affected blood sample, and as a result weigh more, Kosaka told Brazil's leading G1 news website. In addition, the process causes the cancerous cells to change color, indicating the presence of a malignant tumor, she added.

The sensor, not expected to be on the market for 10 more years, may miss only two out of 10,000 samples, and can also be used to detect the onset of hepatitis and Alzheimer's, according to G1.

"Currently, there is no method that can detect very low concentrations of molecules," said Kosaka.

Studies still need to be done to improve the nano-sensor so it can identify the type of cancerous cells present in a sample, such as gastrointestinal or pancreatic.

According to the World Health Organization, 21.4 million cases of cancer are detected around the globe each year.

Source: IANS


Recommended Reading

Latest Cancer News

Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Lung Cancer: The Survival Advantage of Lobectomy Over Wedge Resection
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Nano-Sensor Detects Cancer Even Before Initial Symptoms Appear, Prevents Need for Biopsy Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests